The Certara Blog

Author: Venkateswari Muthukrishnan

Dr. Venkateswari Muthukrishnan joined Certara in 2012. She is responsible for Training and Pre-sales Support in South Asia Pacific and Middle East. In addition, she provides Training and Support on Phoenix Products: Phoenix WinNonlin, NLME, Connect and IVIVC Toolkit. Prior to joining Certara, she held positions at a number of organizations including: AAI International, FibroGen Inc., Biocon Limited, Nektar Therapeutics India Pvt. Ltd., PharMantra Consulting Services, and BITS-Pilani (HYD).

Recent Posts

Accomplish More with Phoenix

Accomplish More with Phoenix

Phoenix 8.1, the newest version of Certara’s innovative PK/PD modeling and simulation software used globally by researchers and drug developers in pharma, academia, and regulatory agencies, will be available on June 15, 2018. Major enhancements were introduced in the Phoenix workbench last year. And as an ongoing commitment to support compliance and efficiency, many features […]

Read More
Conventional & Mechanistic IVIVC - Complementary or Clashing Methods?

Conventional & Mechanistic IVIVC: Complementary or Clashing Methods?

An IVIVC (in vitro-in vivo correlation) is a mathematical relationship that predicts key pharmacokinetic parameters (Cmax, AUC) from in vitro dissolution data. Drug developers use IVIVCs for 3 major reasons: To serve as a surrogate for human bioequivalence (BE) studies To support and/or validate the use of dissolution methods and specifications To assist in quality […]

Read More
Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog